FDA should return to 'science-based' agency
13th Nov 2006, 20:24 GMT
Congress this month likely will consider a bill to reform FDA, "but the legislation lacks the vision and depth needed for a real return to a science-based FDA," Susan Wood, a research professor for the Project on Scientific Knowledge and Public Policy at the George Washington University School of Public Health and Health Services and former assistant commissioner for women's health at FDA, writes in a Boston Globe opinion piece.
FDA should return to 'science-based' agency related news:
- EPA Honors Five Great Lakes Communities for Brownfields Efforts — RedOrbit News - Science
- Sakhalin-2 Disregarded Environmental Risks, Hence Suspension - Russian Ministry — RedOrbit News - Science
- ACT-AD Coalition Calls FDA's New Focus on Neurological Diseases a Positive 1st Step — FDA News News from StratCenter.com
- Can't See City for the Trees -- That's New Forester's Goal — RedOrbit News - Science
- FDA Requirements Block Effective Treatment — Mises Economics Blog
- Drug Safety Reform and Risk Management Plans - A Test Case? Senior FDA Policymakers and Experts to Answer Urgent Questions at Windhover's FDA/CMS Summit Dec 4-5, Washington, DC — RedOrbit News - Health
- No more space for space as tickets sell out — PhysOrg.com - latest science and technology news
- FDA Seeks Boost in Drug Company Fees — Financial News News from StratCenter.com
- Phosphorus Found to Be Another Culprit in Gulf of Mexico's 'Dead Zone' — PhysOrg.com - latest science and technology news
- Dendreon Asks FDA to OK Prostate Drug — Government/ Industry Regulation News from StratCenter.com
Latest news from News-Medical News Feed:
- Children being set up for heart disease later on in life
- New cancer treatments use body's own immune system to kill melanoma tumours
- IVF success compromised by heavy smoking
- Why we all carry on with those bad habits
- Sugar and fizzy drinks linked to pancreatic cancer
- SpectraScience files new patent application
- Global Patient Safety Challenge: Clean Care is Safer Care
- FDA strengthens program for medical devices
- Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer
- More U.S residents trust TV for health info